These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17610788)

  • 1. Measures of association: an overview with examples from Canadian emergency medicine research.
    Worster A; Rowe BH
    CJEM; 2001 Jul; 3(3):219-23. PubMed ID: 17610788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The number needed to treat (NNT) and the number needed to harm (NNH)].
    Suter K; Briel M; Günther J
    Med Monatsschr Pharm; 2015 Mar; 38(3):103-6. PubMed ID: 26364396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized comparison of patients' understanding of number needed to treat and other common risk reduction formats.
    Sheridan SL; Pignone MP; Lewis CL
    J Gen Intern Med; 2003 Nov; 18(11):884-92. PubMed ID: 14687273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative risk, absolute risk and number needed to treat: basic concepts.
    Carneiro AV
    Rev Port Cardiol; 2009 Jan; 28(1):83-7. PubMed ID: 19388495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerable variation in NNT - a study based on Monte Carlo simulations.
    Wisløff T; Aalen OO; Kristiansen IS
    J Clin Epidemiol; 2011 Apr; 64(4):444-50. PubMed ID: 20947294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of presenting risk information in different formats to cardiologists. A Latin American survey.
    Borracci RA; Piñeiro DJ; Arribalzaga EB
    Arch Cardiol Mex; 2015; 85(1):3-8. PubMed ID: 25450431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute risk reduction in total mortality with implantable cardioverter defibrillators: analysis of primary and secondary prevention trial data to aid risk/benefit analysis.
    Betts TR; Sadarmin PP; Tomlinson DR; Rajappan K; Wong KC; de Bono JP; Bashir Y
    Europace; 2013 Jun; 15(6):813-9. PubMed ID: 23365069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
    Wells GA; Cranney A; Peterson J; Boucher M; Shea B; Robinson V; Coyle D; Tugwell P
    Cochrane Database Syst Rev; 2008 Jan; (1):CD001155. PubMed ID: 18253985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do drug treatment POEMs report data in clinically useful ways?
    Duncan B; Ables AZ
    J Fam Pract; 2013 Feb; 62(2):E1-5. PubMed ID: 23405382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Concepts important in the interpretation of therapeutic studies. Absolute risk reduction (ARR), relative risk reduction (RRR), number needed to treat (NNT)].
    Steurer J
    Praxis (Bern 1994); 1997 Apr; 86(15):614. PubMed ID: 9213913
    [No Abstract]   [Full Text] [Related]  

  • 11. Reporting number needed to treat and absolute risk reduction in randomized controlled trials.
    Nuovo J; Melnikow J; Chang D
    JAMA; 2002 Jun; 287(21):2813-4. PubMed ID: 12038920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk and prevention in cardiovascular diseases].
    Gulácsi L; Edes I; Hajdú E; Tóthfalusi L
    Orv Hetil; 2004 Dec; 145(50):2515-21. PubMed ID: 15662751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of using a safety checklist on patient complications after surgery: a systematic review and meta-analysis.
    Gillespie BM; Chaboyer W; Thalib L; John M; Fairweather N; Slater K
    Anesthesiology; 2014 Jun; 120(6):1380-9. PubMed ID: 24845919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How patient outcomes are reported in drug advertisements.
    Lexchin J
    Can Fam Physician; 1999 May; 45():1213-6. PubMed ID: 10349065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based dermatology: number needed to treat and its relation to other risk measures.
    Manriquez JJ; Villouta MF; Williams HC
    J Am Acad Dermatol; 2007 Apr; 56(4):664-71. PubMed ID: 17367615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Number needed to treat: a descriptor for weighing therapeutic options.
    Wen L; Badgett R; Cornell J
    Am J Health Syst Pharm; 2005 Oct; 62(19):2031-6. PubMed ID: 16174840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Using "number needed to treat" to interpret treatment effect].
    Ke DS
    Acta Neurol Taiwan; 2006 Jun; 15(2):120-6. PubMed ID: 16871900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Number needed to treat (NNT), an index for clinical therapeutic efficacy assessment--its significance and application].
    Cao HJ; Liu JP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jul; 30(7):752-6. PubMed ID: 20929138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biostatistics Series Module 8: Assessing Risk.
    Hazra A; Gogtay N
    Indian J Dermatol; 2017; 62(2):123-129. PubMed ID: 28400629
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.